Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation
α-Synuclein (aSyn) aggregation is an attractive target for therapeutic development for a range of neurodegenerative conditions, collectively termed synucleinopathies. Here, we probe the mechanism of action of a peptide 4554W, (KDGIVNGVKA), previously identified through intracellular library screenin...
Main Authors: | James H. Torpey, Richard M. Meade, Ravina Mistry, Jody M. Mason, Jillian Madine |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2020.561462/full |
Similar Items
-
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
by: Scott G. Allen, et al.
Published: (2023-11-01) -
Alpha-synuclein structure, functions, and interactions
by: Fatemeh Nouri Emamzadeh
Published: (2016-01-01) -
Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
by: Janett Köppen, et al.
Published: (2020-01-01) -
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
by: Richard M. Meade, et al.
Published: (2019-07-01) -
Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)